Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2CNS 1Breast 1

Conditions

Pheochromocytoma 2Paraganglioma 1

Interventions

lanreotide 5Octreotide 5Everolimus 4Dexmedetomidine 3Cabergoline 3pasireotide 2Phenoxybenzamine 2Carboplatin 2trametinib 1testosterone enanthate 1surufatinib 1selpercatinib 1pralsetinib 1pegvisomant 1lutetium Lu 177 dotatate 1lenvatinib 1larotrectinib 1gadoteridol 1gadoterate meglumine 1gadolinium ethoxybenzyl DTPA 1gadodiamide 1gadobutrol 1gadobenic acid 1entrectinib 1dabrafenib 1candesartan 1arginyllysine 1anlotinib 1Vitamin D 1Trimethoprim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Phenoxybenzamine × Endocrine × Clear all
NCT05702944 2025-06-12

The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma

Seoul National University Hospital

Phase 4 Recruiting
24 enrolled
CNSEndocrine

Paraganglioma, Pheochromocytoma

NCT01379898 2024-09-19

PRESCRIPT

University Medical Center Groningen

Phase 4 Completed
134 enrolled
Endocrine

Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡